FLC
BIOSU

Fifth Lane Capital’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Fifth Lane Capital’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,000
Closed -$1.03M – 311
2022
Q2 		$1.03M Buy
+30,000
New +$300K 0.65% 41
2022
Q1 		– Sell
-102,500
Closed -$1.02M – 399
2021
Q4 		$1.02M Buy
+102,500
New +$1.03M 0.6% 42

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Fifth Lane Capital's BIOSU Position: Q3 2022 in Review

Fifth Lane Capital sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q3 2022, closing a stake of 30,000 shares — an estimated $1.03M sold.

Fifth Lane Capital first reported a position in BIOSU in Q4 2021 and held it in 2 quarters. The position peaked at $1.03M in Q2 2022. 15 funds tracked by Wall St. Rank hold BIOSU as of Q3 2022.

  • Fifth Lane Capital reported no remaining BioPlus Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
  • Fifth Lane Capital sold 30,000 BioPlus Acquisition Corp. Unit shares in Q3 2022, an estimated $1.03M.
  • Fifth Lane Capital first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
  • Fifth Lane Capital's BioPlus Acquisition Corp. Unit position peaked at $1.03M in Q2 2022.
  • 15 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q3 2022.

Based on Fifth Lane Capital's 13F filing for Q3 2022, filed 14 Nov 2022.